Literature DB >> 7973215

Interim analysis: the alpha spending function approach.

D L DeMets1, K K Lan.   

Abstract

Interim analysis of accumulating data in a clinical trial is now an established practice for ethical and scientific reasons. Repeatedly testing interim data can inflate false positive error rates if not handled appropriately. Group sequential methods are a commonly used frequentist approach to control this error rate. Motivated by experience of clinical trials, the alpha spending function is one way to implement group sequential boundaries that control the type I error rate while allowing flexibility in how many interim analyses are to be conducted and at what times. In this paper, we review the alpha spending function approach, and detail its applicability to a variety of commonly used statistical procedures, including survival and longitudinal methods.

Mesh:

Substances:

Year:  1994        PMID: 7973215     DOI: 10.1002/sim.4780131308

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  115 in total

1.  Regulatory perspectives on data safety monitoring boards: protecting the integrity of data.

Authors:  Robert Hemmings; Simon Day
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

2.  Extracranial-intracranial bypass surgery for stroke prevention in hemodynamic cerebral ischemia: the Carotid Occlusion Surgery Study randomized trial.

Authors:  William J Powers; William R Clarke; Robert L Grubb; Tom O Videen; Harold P Adams; Colin P Derdeyn
Journal:  JAMA       Date:  2011-11-09       Impact factor: 56.272

Review 3.  Repeated looks at accumulating data: to correct or not to correct?

Authors:  Ingeborg van der Tweel
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

4.  Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer.

Authors:  William U Shipley; Wendy Seiferheld; Himanshu R Lukka; Pierre P Major; Niall M Heney; David J Grignon; Oliver Sartor; Maltibehn P Patel; Jean-Paul Bahary; Anthony L Zietman; Thomas M Pisansky; Kenneth L Zeitzer; Colleen A F Lawton; Felix Y Feng; Richard D Lovett; Alexander G Balogh; Luis Souhami; Seth A Rosenthal; Kevin J Kerlin; James J Dignam; Stephanie L Pugh; Howard M Sandler
Journal:  N Engl J Med       Date:  2017-02-02       Impact factor: 91.245

5.  Surgical versus nonsurgical therapy for lumbar spinal stenosis.

Authors:  James N Weinstein; Tor D Tosteson; Jon D Lurie; Anna N A Tosteson; Emily Blood; Brett Hanscom; Harry Herkowitz; Frank Cammisa; Todd Albert; Scott D Boden; Alan Hilibrand; Harley Goldberg; Sigurd Berven; Howard An
Journal:  N Engl J Med       Date:  2008-02-21       Impact factor: 91.245

Review 6.  [Trial sequential analysis : Sample size calculation for reliable meta-analyses].

Authors:  S Weibel; P Kranke
Journal:  Anaesthesist       Date:  2017-01-31       Impact factor: 1.041

7.  Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis.

Authors:  Robert J Fox; Christopher S Coffey; Merit E Cudkowicz; Trevis Gleason; Andrew Goodman; Eric C Klawiter; Kazuko Matsuda; Michelle McGovern; Robin Conwit; Robert Naismith; Akshata Ashokkumar; Robert Bermel; Dixie Ecklund; Maxine Koepp; Jeffrey Long; Sneha Natarajan; Srividya Ramachandran; Thomai Skaramagas; Brenda Thornell; Jon Yankey; Mark Agius; Khurram Bashir; Bruce Cohen; Patricia Coyle; Silvia Delgado; Dana Dewitt; Angela Flores; Barbara Giesser; Myla Goldman; Burk Jubelt; Neil Lava; Sharon Lynch; Augusto Miravalle; Harold Moses; Daniel Ontaneda; Jai Perumal; Michael Racke; Pavle Repovic; Claire Riley; Christopher Severson; Shlomo Shinnar; Valerie Suski; Bianca Weinstock-Gutman; Vijayshree Yadav; Aram Zabeti
Journal:  Contemp Clin Trials       Date:  2016-08-10       Impact factor: 2.226

8.  Randomized trial of adjuvant thalidomide versus observation in patients with completely resected high-risk renal cell carcinoma.

Authors:  Vitaly Margulis; Surena F Matin; Nizar Tannir; Pheroze Tamboli; Yu Shen; Marisa Lozano; David A Swanson; Eric Jonasch; Christopher G Wood
Journal:  Urology       Date:  2008-10-31       Impact factor: 2.649

9.  Vitamins C and E for prevention of pre-eclampsia in women with type 1 diabetes (DAPIT): a randomised placebo-controlled trial.

Authors:  David R McCance; Valerie A Holmes; Michael J A Maresh; Christopher C Patterson; James D Walker; Donald W M Pearson; Ian S Young
Journal:  Lancet       Date:  2010-06-26       Impact factor: 79.321

10.  Interpreting meta-analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV-infected individuals.

Authors:  Kristian Thorlund; Aranka Anema; Edward Mills
Journal:  Clin Epidemiol       Date:  2010-08-09       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.